Skip to main content
. 2024 Mar 6;14(4):101. doi: 10.1007/s13205-024-03942-7

Table 6.

BMC evaluation during PRME administration period

Regions SC (g) OVX (g) OVX + PRME (g) OVX + Std (g)
Arms 0.87 ± 0.12 0.33 ± 0.17 0.47 ± 0.35 0.58 ± 0.34
Legs 1.87 ± 0.31 2.1 ± 0.66 1.98 ± 0.82 1.76 ± 0.84
Trunk 2.9 ± 0.52 1.93 ± 0.38 2.32 ± 0.51 2.78 ± 0.54
Total 8.03 ± 0.35 6.97 ± 0.21 7.37 ± 0.46 7.6 ± 0.39
TBLH 5.63 ± 0.21 4.4 ± 0.53 4.8 ± 0.68 5.12 ± 0.54

Where; OVX ovariectomized rat, SC Sham control, OVX + PRME variectomized rat + Pterospermum rubiginosum methanolic extract, OVX + std ovariectomized rat + alendronic acid; bone mineral content—BMC, g grams